Ligands with its PDB code and its tanimoto calculated from the molecule, present in the database, which has for MMscode: MMs00160232

Ligand	Ligand name	Chain	PDB	Tanimoto
XED	DEXTROFLOXACINE	A,B	2BML	0.71
MBQ	2-HYDROXY-5-({1-[(4-METHYLPHENOXY)METHYL]-3-OXOPROP-1-ENYL}AMINO)-L-TYROSINE	A	1SIH	0.73
D27	2-{[(2E)-3-(3,4-dimethoxyphenyl)prop-2-enoyl]amino}benzoic acid	A,B,C,D	2VD0	0.71
FL1	5-{[({2-[4-(AMINOSULFONYL)PHENYL]ETHYL}AMINO)CARBONOTHIOYL]AMINO}-2-(6-HYDROXY-3-OXO-3H-XANTHEN-9-YL)BENZOIC ACID	A	2F14	0.75
03R	2-({6-{3-[AMINO(IMINO)METHYL]PHENOXY}-3,5-DIFLUORO-4-[(1-METHYL-3-PHENYLPROPYL)AMINO]-2-PYRIDINYL}OXY)BENZOIC ACID	H,L	2AEI	0.71
R2C	5-METHOXY-2-[(4-PHENOXYPHENYL)AMINO]BENZOIC ACID	A	2PRL	0.73
515	3-({5-[(N-ACETYL-3-{4-[(CARBOXYCARBONYL)(2-CARBOXYPHENYL)AMINO]-1-NAPHTHYL}-L-ALANYL)AMINO]PENTYL}OXY)-2-NAPHTHOIC ACID	A	1NNY	0.74
FLG	FLUORESCEINYLTHIOUREIDO	A,B	1OCB	0.81
PCY	PACTAMYCIN	A,D,H,N	1HNX	0.71
R6G	RHODAMINE 6G	B	2V3L	0.8
NOV	NOVOBIOCIN	A,B	1KIJ	0.71
NOV	NOVOBIOCIN	A,B	1S14	0.71
NOV	NOVOBIOCIN	A	1AJ6	0.71
MUS	4-METHYL-2-OXO-2H-CHROMEN-7-YL 5-(ACETYLAMINO)-3,5-DIDEOXY-L-ERYTHRO-NON-2-ULOPYRANOSIDONIC ACID	A	1S0J	0.7
429	2-{4-[2-ACETYLAMINO-3-(4-CARBOXYMETHOXY-3-HYDROXY-PHENYL)-PROPIONYLAMINO]-BUTOXY}-6-HYDROXY-BENZOIC ACID METHYL ESTER	A	1QXK	0.71
418	2-{4-[2-(S)-ALLYLOXYCARBONYLAMINO-3-{4-[(2-CARBOXY-PHENYL)-OXALYL-AMINO]-PHENYL}-PROPIONYLAMINO]-BUTOXY}-6-HYDROXY-BENZOIC ACID METHYL ESTER	A	1PH0	0.76
323	2-[3,6-bis(dimethylamino)xanthen-9-yl]-5-methanoyl-benzoate	A,P,Q	3D1F	0.74
D55	4-(2-aminoethoxy)-N-(2,5-diethoxyphenyl)-3,5-dimethylbenzamide	A	2VIQ	0.72
U04	({3-[1-(4-HYDROXY-2-OXO-2H-CHROMEN-3-YL)-PROPYL]-PHENYLCARBAMOYL}-METHYL)-CARBAMIC ACID TERT-BUTYL ESTER	A	4UPJ	0.75
F79	2-(2-AMINOETHOXY)-3-ETHYL-6-{[(4-FLUOROPHENYL)SULFONYL]AMINO}BENZOIC ACID	A	2EA4	0.72
CYF	5-[2-(2-AMINO-2-CARBAMOYL-ETHYLSULFANYL)-ACETYLAMINO]-2-(3,6-DIHYDROXY-9,9A-DIHYDRO-3H-XANTHEN-9-YL)-BENZOIC ACID	L,P	1MPA	0.76
CYF	5-[2-(2-AMINO-2-CARBAMOYL-ETHYLSULFANYL)-ACETYLAMINO]-2-(3,6-DIHYDROXY-9,9A-DIHYDRO-3H-XANTHEN-9-YL)-BENZOIC ACID	L,P	2MPA	0.76
CYF	5-[2-(2-AMINO-2-CARBAMOYL-ETHYLSULFANYL)-ACETYLAMINO]-2-(3,6-DIHYDROXY-9,9A-DIHYDRO-3H-XANTHEN-9-YL)-BENZOIC ACID	I,L	1DZH	0.76
MDC	N-[2-(1-MALEIMIDYL)ETHYL]-7-DIETHYLAMINOCOUMARIN-3-CARBOXAMIDE	A	1A54	0.73
RHO	TETRAMETHYLRHODAMINE-5-MALEIMIDE	A	1J6Z	0.76
RHO	TETRAMETHYLRHODAMINE-5-MALEIMIDE	A	1NWK	0.76
RHQ	RHODAMINE 6G	A,B,D,E	1JUS	0.78
RHQ	RHODAMINE 6G	A,B,D,E	3BR5	0.78
RHQ	RHODAMINE 6G	A,D,E	3BR6	0.78
RHQ	RHODAMINE 6G	A,B	3D6Z	0.78
RHQ	RHODAMINE 6G	A	1OY8	0.78
RHQ	RHODAMINE 6G	A	1T9V	0.78
FLQ	N-[6-(ACETYLAMINO)HEXYL]-3',6'-DIHYDROXY-3-OXO-3H-SPIRO[2-BENZOFURAN-1,9'-XANTHENE]-6-CARBOXAMIDE	C	2FDC	0.76
44C		A	2FBR	0.73
VG4	N-[(1S,2R)-1-benzyl-3-{[(1S)-2-(cyclohexylamino)-1-methyl-2-oxoethyl]amino}-2-hydroxypropyl]-3-(2-oxo-2,3-dihydro-1H-pyrrol-1-yl)-5-propoxybenzamide	A	2VIZ	0.7
R36	4-AMINO-N-{4-[2-(2,6-DIMETHYL-PHENOXY)-ACETYLAMINO]-3-HYDROXY-1-ISOBUTYL-5-PHENYL-PENTYL}-BENZAMIDE	A	1LEE	0.71
NBQ	2-HYDROXY-5-({1-[(2-NAPHTHYLOXY)METHYL]-3-OXOPROP-1-ENYL}AMINO)TYROSINE	A	1SII	0.71
RXD	N-[3-(2-fluoroethoxy)phenyl]-N'-(1,3,4-trioxo-1,2,3,4-tetrahydroisoquinolin-6-yl)butanediamide	A,B,C,D	3DEK	0.71
R37	3-AMINO-N-{4-[2-(2,6-DIMETHYL-PHENOXY)-ACETYLAMINO]-3-HYDROXY-1-ISOBUTYL-5-PHENYL-PENTYL}-BENZAMIDE	A	1LF2	0.73
RFP	RIFAMPICIN	A	1SKX	0.71
RFP	RIFAMPICIN	A	2HW2	0.71
RFP	RIFAMPICIN	C,D	1I6V	0.71
RFP	RIFAMPICIN	C,D	1YNN	0.71
OXI	OXOLINIC ACID	A,B	1KSE	0.71
BPD	N-(M-TRIFLUOROMETHYLPHENYL) PHENOXAZINE-4,6-DICARBOXYLIC ACID	A	1DVY	0.7
561	6-HYDROXY-3-{(4R)-1-[4-(1-NAPHTHYLAMINO)-4-OXOBUTYL]-1,2,3-TRIAZOLIDIN-4-YL}-1-BENZOFURAN-5-CARBOXYLIC ACID	A,B	2QCT	0.73
371	2-(3,4-DIHYDROXYPHENYL)-8-(1,1-DIOXIDOISOTHIAZOLIDIN-2-YL)-3-HYDROXY-6-METHYL-4H-CHROMEN-4-ONE	A	2DUV	0.74
RQ3	2-{4-[(3,5-DIMETHYLANILINO)-CARBONYL-METHYL]-PHENOXY}-2-METHYLPROPIONIC ACID	A,B,C,D	1G9V	0.73
6CA		A	2FLM	0.73